Zobrazeno 1 - 10
of 152
pro vyhledávání: '"Musgrove H"'
Autor:
Musgrove H; Author Affiliations: Department of Quality and Safety (Mss Musgrove, Ruby, Chami) and Surgical Intensive Care Unit (Mss Morales, Thompson, and Dr Gupta), Henry Ford Hospital, Detroit, MI., Morales P, Ruby A, Thompson Y, Chami E, Gupta A
Publikováno v:
Journal of nursing care quality [J Nurs Care Qual] 2024 Oct-Dec 01; Vol. 39 (4), pp. 301-303. Date of Electronic Publication: 2024 May 16.
Autor:
Musgrove H; Surgical Intensive Care Unit, Henry Ford Hospital, Detroit, Michigan., Ruby A; Department of Quality and Safety, Henry Ford Hospital, Detroit, Michigan., Chami E; Department of Quality and Safety, Henry Ford Hospital, Detroit, Michigan., Pollak E; Department of Anesthesiology, Henry Ford Hospital and Henry Ford Medical Group, Detroit, Michigan., Suleyman G; Department of Infectious Diseases, Henry Ford Hospital, Detroit, Michigan., Gupta A; Department of Surgery, Henry Ford Hospital, Detroit, Michigan.
Publikováno v:
Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2024 May; Vol. 45 (5), pp. 674-676. Date of Electronic Publication: 2024 Jan 02.
Autor:
Draus C; Center for Nursing Research and Evidence-Based Practice (Drs Draus and Mianecki), Surgical Intensive Care Unit (Ms Musgrove), B4/F1 (Ms Greggs), Medical Intensive Care Unit (Ms Halash), Labor and Delivery, High Risk Antepartum (Dr Bellany), and Labor and Delivery/I3 High Risk Antenatal (Ms Mackenzie), Henry Ford Hospital, Detroit, Michigan; Henry Ford Health System, Detroit, Michigan (Dr Bastien); and Henry Ford Health System, West Bloomfield, Michigan (Ms Lewis)., Mianecki TB, Musgrove H, Bastien DJ, Greggs D, Halash C, Larry-Osman Bellamy C, Lewis A, Mackenzie W
Publikováno v:
Journal of nursing care quality [J Nurs Care Qual] 2022 Apr-Jun 01; Vol. 37 (2), pp. 110-116.
Autor:
McCoull W; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Boyd S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Brown MR; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Coen M; Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Collingwood O; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Davies NL; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Doherty A; Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Fairley G; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Goldberg K; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Hardaker E; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., He G; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P. R. China., Hennessy EJ; Oncology R&D, AstraZeneca, Gatehouse Park, Waltham, Massachusetts 02451, United States., Hopcroft P; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Hodgson G; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Jackson A; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Jiang X; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P. R. China., Karmokar A; Oncology R&D, AstraZeneca, Mereside, Alderley Park, Macclesfield SK10 4TG, U.K., Lainé AL; Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Lindsay N; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Mao Y; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Markandu R; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., McMurray L; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., McLean N; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Mooney L; Oncology R&D, AstraZeneca, Mereside, Alderley Park, Macclesfield SK10 4TG, U.K., Musgrove H; Oncology R&D, AstraZeneca, Mereside, Alderley Park, Macclesfield SK10 4TG, U.K., Nissink JWM; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Pflug A; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Reddy VP; Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Rawlins PB; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Rivers E; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Schimpl M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Smith GF; Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Tentarelli S; Oncology R&D, AstraZeneca, Gatehouse Park, Waltham, Massachusetts 02451, United States., Travers J; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Troup RI; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Walton J; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Wang C; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P. R. China., Wilkinson S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Williamson B; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Winter-Holt J; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Yang D; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P. R. China., Zheng Y; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P. R. China., Zhu Q; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P. R. China., Smith PD; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2021 Sep 23; Vol. 64 (18), pp. 13524-13539. Date of Electronic Publication: 2021 Sep 03.
Autor:
Skinner, M, Philp, K, Lengel, D, Coverley, L, Lamm Bergström, E, Glaves, P, Musgrove, H, Prior, H, Braddock, M, Huby, R, Curwen, J O, Duffy, P, Harmer, A R
Publikováno v:
British Journal of Pharmacology; May2014, Vol. 171 Issue 9, p2308-2320, 13p, 1 Chart, 6 Graphs
Autor:
Lengel D; AstraZeneca R&D Alderley Park Macclesfield, Cheshire, SK10 4TG, United Kingdom., Lamm Bergström E; AstraZeneca R&D Alderley Park Macclesfield, Cheshire, SK10 4TG, United Kingdom., Barthlow H; AstraZeneca R&D Alderley Park Macclesfield, Cheshire, SK10 4TG, United Kingdom., Oldman K; AstraZeneca R&D Alderley Park Macclesfield, Cheshire, SK10 4TG, United Kingdom., Musgrove H; AstraZeneca R&D Alderley Park Macclesfield, Cheshire, SK10 4TG, United Kingdom., Harmer A; AstraZeneca R&D Alderley Park Macclesfield, Cheshire, SK10 4TG, United Kingdom., Valentin JP; AstraZeneca R&D Alderley Park Macclesfield, Cheshire, SK10 4TG, United Kingdom., Duffy P; AstraZeneca R&D Alderley Park Macclesfield, Cheshire, SK10 4TG, United Kingdom., Braddock M; AstraZeneca R&D Alderley Park Macclesfield, Cheshire, SK10 4TG, United Kingdom., Curwen J; AstraZeneca R&D Alderley Park Macclesfield, Cheshire, SK10 4TG, United Kingdom.
Publikováno v:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2015 Oct; Vol. 3 (5), pp. e00176. Date of Electronic Publication: 2015 Sep 15.
Autor:
Aherne, GW, Ward, E, Lawrence, N, Dobinson, D, Clarke, SJ, Musgrove, H, Sutcliffe, F, Stephens, T, Jackman, AL, Aherne, G W, Clarke, S J, Jackman, A L
Publikováno v:
British Journal of Cancer; Jan1998, Vol. 77 Issue 2, p221-226, 6p
Publikováno v:
Journal of Advanced Nursing (John Wiley & Sons, Inc.); Jan2025, Vol. 81 Issue 1, p171-180, 10p
Autor:
Cairney SA; School of Psychological Sciences, University of Manchester, 3rd Floor Zochonis Building, Brunswick Street, Manchester M13 9PL, UK. Scott.Cairney@postgrad.manchester.ac.uk, Durrant SJ, Musgrove H, Lewis PA
Publikováno v:
Experimental brain research [Exp Brain Res] 2011 Sep; Vol. 214 (1), pp. 83-92. Date of Electronic Publication: 2011 Jul 29.
Autor:
Camarda, Nicholas D., Qing Lu, Meola, Dawn M., Man, Joshua J., Zeyuan Song, Travers, Richard J., Lopez, Katherine E., Powers, Sarah N., Papanastasiou, Malvina, DeRuff, Katherine C., Mullahoo, James, Egri, Shawn B., Davison, Desiree, Sebastiani, Paola, Eblen, Scott T., Buchsbaum, Rachel, Huggins, Gordon S., London, Cheryl A., Jaffe, Jacob D., Upshaw, Jenica N.
Publikováno v:
Clinical Science; 9/15/2024, Vol. 138 Issue 18, p1131-1150, 20p